| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524850 1-{1-[4-(6-hydroxy-5-isobutyl-3-phenylpyrazin-2-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; serine/threonine protein kinase; antiproliferative |
| 04/28/2009 | US7524848 Diaza heterocyclic amide compounds and their uses |
| 04/28/2009 | US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/28/2009 | CA2400176C Substituted piperazine compounds |
| 04/28/2009 | CA2259922C Calcium receptor active compounds |
| 04/23/2009 | WO2009052126A1 PIPERIDINYL AND PIPERAZINYL MODULATORS OF γ-SECRETASE |
| 04/23/2009 | WO2009051910A1 Compounds having activity in increasing ion transport by mutant-cftr and uses thereof |
| 04/23/2009 | WO2006076463A3 Kinase-directed, activity-based probes |
| 04/23/2009 | US20090105452 Non-fluorescent quencher compounds and biomolecular assays |
| 04/23/2009 | US20090105447 Novel Polymers |
| 04/23/2009 | US20090105275 PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE |
| 04/23/2009 | US20090105264 Substituted Nicotinamide Compounds |
| 04/23/2009 | US20090105260 Molecules to Enhance Percutaneous Delivery and Methods for Discovery Therefor |
| 04/23/2009 | US20090105251 Renin inhibitors |
| 04/23/2009 | US20090105208 Substituted Piperazines as CB1 Antagonists |
| 04/23/2009 | CA2702837A1 Piperidinyl and piperazinyl modulators of .gamma.-secretase |
| 04/22/2009 | EP2049473A2 Substituted benzyl amine compounds |
| 04/22/2009 | EP2049466A1 Butyl and butynyl benzyl amine compounds |
| 04/22/2009 | EP1851193B1 Hiv protease inhibitors |
| 04/22/2009 | EP1592389B1 Piperazine-2-carboxamide derivatives |
| 04/22/2009 | CN101415690A Novel tricyclic dihydropyrazines as potassium channel openers |
| 04/22/2009 | CN100481571C Luminescent element material and luminescent element comprising the same |
| 04/21/2009 | US7521552 Process for preparation of substituted amino alcohols |
| 04/21/2009 | US7521451 e.g. 5,6-dimethyl-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione;intravenous, water-soluble compounds useful for manufacturing an anasthetic, sedative agents; side effect reduction |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/16/2009 | WO2009048101A1 Amide compound |
| 04/16/2009 | US20090099360 Method for Cleaning 3-Hydroxyamidinophenylalanine Derivatives by the Precepitation and Recrystallization of Salt and an Aromatic Sulfonic Acid |
| 04/16/2009 | US20090099204 Amide derivative, insecticide containing the same and method for application thereof as insecticide |
| 04/16/2009 | US20090099199 Organic compounds |
| 04/16/2009 | US20090099164 Phenylaminopropanol Derivatives and Methods of Their Use |
| 04/16/2009 | US20090099147 Non-steroidal progesterone receptor modulators |
| 04/16/2009 | CA2702171A1 Amide compound |
| 04/15/2009 | EP2046778A1 Multifunctional bioactive compounds |
| 04/15/2009 | EP1703909B1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 04/15/2009 | CN101407492A New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same |
| 04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
| 04/14/2009 | US7517899 Phenylaminopropanol derivatives and methods of their use |
| 04/14/2009 | US7517884 {5-[4-(4-Trifluoromethyl-phenyl)-piperazine-1-sulfonyl]-indan-2-yl}-acetic acid; peroxisome proliferator activated receptors modulator; antidiabetic, antiinflammatory agent; obesity, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome, ischemia-associated organ injury, diabetes |
| 04/14/2009 | US7517532 Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2385863C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 04/14/2009 | CA2138533C Drugs that enhance synaptic responses mediated by ampa receptors |
| 04/09/2009 | WO2009044007A2 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/09/2009 | WO2009043117A1 Novel aryl potassium channel blockers and uses thereof |
| 04/09/2009 | WO2009021868A3 Novel piperazine amide derivatives |
| 04/09/2009 | WO2008148867A3 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 04/09/2009 | WO2008074997A8 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 04/09/2009 | US20090093493 1-phenylalcoxy-2-beta-phenylethyl derivatives as p-glycoprotein (p-gp) inhibitors useful in drug resistance events |
| 04/09/2009 | US20090093490 Heterocyclylethylbenzamide derivatives |
| 04/09/2009 | US20090093478 N-aroyl cyclic amines |
| 04/09/2009 | US20090093469 Phenylaminopropanol Derivatives and Methods of Their Use |
| 04/09/2009 | US20090091252 Binaphthyl compound and organic light emitting element using the same |
| 04/09/2009 | US20090089939 Indole-derived styryl dye comprising an alkylene linker, a dye composition comprising this dye, and a process for lightening keratin materials using this dye |
| 04/09/2009 | CA2701579A1 Novel aryl potassium channel blockers and uses thereof |
| 04/09/2009 | CA2694288A1 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/08/2009 | EP2045251A1 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
| 04/08/2009 | EP2044038A2 Novel piperazines, pharmaceutical compositions and methods of use thereof |
| 04/08/2009 | EP2044027A2 Fused bicyclic compounds interacting with the histamine h4 receptor |
| 04/08/2009 | EP2044026A1 Method of treatment of glioma brain tumour |
| 04/08/2009 | EP1877364B1 Phenylacetylene derivatives having mglur5 receptor affinity |
| 04/08/2009 | EP1606251B1 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 04/08/2009 | CN101405266A Piperazines and piperidines as mGlur5 potentiators |
| 04/08/2009 | CN101402612A Synthesis of quinocetone |
| 04/08/2009 | CN101402601A Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 04/08/2009 | CN101402587A Substituted acethydrazide derivatives, preparation method and application thereof |
| 04/08/2009 | CN100475822C Synthesis method for producing ecteinascidin compound |
| 04/08/2009 | CN100475794C Method for preparing 2-quinoxaline alcohol |
| 04/08/2009 | CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/07/2009 | US7514437 2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-N,N-dimethylethanamide; to suppress uterine contractions; cyclization of leucine analogs |
| 04/07/2009 | US7514431 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 04/07/2009 | US7514430 Nitrogen compounds such as N-phenyl-N'-{(1R,2S)-2-[(2S)-2-benzyl-6-oxo-morpholin-4-yl-methyl]-cyclohexyl }-urea, used to control chemotactic cytokines, and administered for the prevention of asthma or allergies; inhibition of the migration of eosinophils |
| 04/02/2009 | WO2009041566A1 Preventive or remedy for posterior eye diseases containing quinazolinone derivative or quinoxaline derivative as the active ingredient |
| 04/02/2009 | WO2009041473A1 Organic amine salt of 6-fluoro-3-hydroxy-2-pyrazinecarbonitrile and method for producing the same |
| 04/02/2009 | WO2009040288A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 04/02/2009 | WO2009009501A3 Non-basic melanin concentrating hormone receptor-1 antagonists and methods |
| 04/02/2009 | WO2007115164A3 Amino acid surrogates for peptidic constructs |
| 04/02/2009 | US20090088425 Glucocorticoid receptor antagonists |
| 04/02/2009 | US20090088406 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 04/02/2009 | CA2700490A1 Organic amine salt of 6-fluoro-3-hydroxy-2-pyrazinecarbonitrile and method for producing the same |
| 04/02/2009 | CA2700277A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 04/01/2009 | EP2042490A2 Benzimidazole derivatives as vanilloid receptor antagonists |
| 04/01/2009 | EP2041088A1 Glycine transporter-1 inhibitors |
| 04/01/2009 | CN101400659A Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 04/01/2009 | CN101400658A Photoactive compounds and compositions and uses thereof |
| 03/31/2009 | US7511168 Alkylation of a hydroxy-protected 2-(amido, carboxy, or thiocarboxy)methyl-4-hydroxypent-2-enone at the 3-position, deprotecting, resolving diastereomers by crystallization; simplification; cost efficiency |
| 03/31/2009 | US7511149 Using ruthenium tetraoxide and alkali metal permanganate |
| 03/31/2009 | US7511047 Kinase inhibitors |
| 03/31/2009 | US7511043 farnesoid X receptor; to mitigate and thereby treat hypercholesterolemia; antagonists, which block the negative feedback downregulation of cyp7a expression produced by certain cholic acids |
| 03/31/2009 | US7511041 Fused azole-pyrimidine derivatives |
| 03/31/2009 | US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 03/31/2009 | CA2448602C Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
| 03/26/2009 | WO2009039397A2 Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer |
| 03/26/2009 | WO2009039091A1 Method of treatment |
| 03/26/2009 | WO2009037642A1 Heterocyclic scaffolds useful for preparation of combinatorial libraries, libraries and methods of preparation thereof |
| 03/26/2009 | US20090082364 Deuterium-enriched levocedtirizine |
| 03/26/2009 | US20090082362 Use of capsaicin receptor antagonists to treat symptoms of tear gas exposure |